Home › Cancer (all types) › NCT06962995

Multi-Cancer Detection Observational Cohort Study

Who can join

Ages 21 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Has Mayo Clinic medical record number
* Has undergone (within last 6 months) or scheduled to undergo a multi-cancer detection test (MCD) as ordered by provider
* Able to provide informed consent
* ≥ 21 years old
* Ability to provide blood sample

Exclusion Criteria:

* Individuals who have situations that would limit compliance with the study requirements
* Institutionalized (i.e. Federal Medical Prison)
* Known pregnancy (self-reported)
* Currently undergoing active cancer treatment other than adjuvant hormone therapy
* Invasive cancer diagnosis within the last 3 years

About the study

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

What is being tested

• Blood Sample (procedure)
• Surveys (other)

Sponsor: Mayo Clinic · Participants: 500 · Started: May 7, 2025

Contact the study team

• Clinical Trials Referral Office · Phone: 855-776-0015

Official record on ClinicalTrials.gov — NCT06962995

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.